Drug Trial Radar · NCT04753606
Randomized Study of Obicetrapib as an Adjunct to Statin Therapy
Last checked: Nov 19, 2026Latest source record: Jul 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Feb 18, 2021
Primary completion
May 24, 2021
Study completion Aug 30, 2021
Sponsor
- Lead sponsor
- NewAmsterdam PharmaIndustry
- Sponsor type
- Industry
- First posted
- Feb 15, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be a placebo-controlled, double-blind, randomized, phase 2 dose-finding study to evaluate the efficacy, safety, and tolerability of obicetrapib as an adjunct to high-intensity statin therapy.
Conditions
- Dyslipidemias
- High Cholesterol
- Hypercholesterolemia
Interventions
ObicetrapibDrug
tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) [Friedewald]Time frame: 8-weeks
- Median Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) [Friedewald]Time frame: 8-Weeks
- LS Mean Percent Change Iin Low-Density Lipoprotein Cholesterol (LDL-C) [Friedewald]Time frame: 8-Weeks
- Mean Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) [PUC]Time frame: 8-Weeks
- Median Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) [PUC]Time frame: 8-Weeks
- LS Mean Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) [PUC]Time frame: 8-Weeks
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group
Anniston, Alabama
National Research Institute - Huntington Park
Huntington Park, California
National Research Institute - Wilshire
Los Angeles, California
Clinical Trials Research
Sacramento, California
Jacksonville Center for Clinical Research
Jacksonville, Florida
Ocala Cardiovascular Research
Ocala, Florida
Progressive Medical Research
Port Orange, Florida
IACT Health
Columbus, Georgia
Evanston Premier Healthcare Research LLC
Evanston, Illinois
Midwest Institute for Clinical Research
Indianapolis, Indiana
Oakland Medical Research Center
Troy, Michigan
Diabetes and Endocrinology Consultants, P.C.
Morehead City, North Carolina
Lillestol Research, LLC
Fargo, North Dakota
Metabolic and Atherosclerosis Research Center
Cincinnati, Ohio
Summit Research Group, LLC
Munroe Falls, Ohio
Monument Health Clinical Research
Rapid City, South Dakota
Health Concepts
Rapid City, South Dakota
Juno Research, LL
Houston, Texas
Manassas Clinical Research Center
Manassas, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.